Microenvironment drug resistance in multiple myeloma: emerging new players-Reference-Cited by-同舟云学术

Microenvironment drug resistance in multiple myeloma: emerging new players

Published:2016-07-26 Issue:37 Volume:7 Page:60698-60711
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Di Marzo Lucia¹,Desantis Vanessa¹,Solimando Antonio Giovanni¹,Ruggieri Simona²,Annese Tiziana²,Nico Beatrice²,Fumarulo Ruggiero³,Vacca Angelo¹,Frassanito Maria Antonia³

Affiliation:

1. Department of Biomedical Sciences and Human Oncology, Internal Medicine Section, University of Bari Medical School, Bari, Italy

2. Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy

3. Department of Biomedical Sciences and Human Oncology, General Pathology Section, Bari, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction;International Journal of Molecular Sciences;2024-08-16

2. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets;Pathology - Research and Practice;2024-08

3. Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors;Diagnostic Pathology;2024-07-18

4. TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma;Annals of Hematology;2024-06-20

5. Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells;Heliyon;2024-06